Skip to main content

and
  1. Article

    Open Access

    Hepatic Cyst Infection During Use of the Somatostatin Analog Lanreotide in Autosomal Dominant Polycystic Kidney Disease: An Interim Analysis of the Randomized Open-Label Multicenter DIPAK-1 Study

    The DIPAK-1 Study investigates the reno- and hepatoprotective efficacy of the somatostatin analog lanreotide compared with standard care in patients with later stage autosomal dominant polycystic kidney diseas...

    Marten A. Lantinga, Hedwig M. A. D’Agnolo, Niek F. Casteleijn in Drug Safety (2017)